ロード中...
Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
Multiple sclerosis (MS), a chronic demyelinating neuroinflammatory disease of the central nervous system, is the most common neurological disorder leading to disability in young adulthood. In the last 2 decades, numerous treatments for relapsing–remitting MS have been approved with eleven treatment...
保存先:
| 出版年: | Patient Prefer Adherence |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4332317/ https://ncbi.nlm.nih.gov/pubmed/25709412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S61651 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|